URGN INVESTORS: UroGen Pharma Ltd. Shareholders are Reminded to Contact BFA Law before the Expiration of the Upcoming July 28 Cl

  • NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.